
GC11627
TCS 2002
Also known as 2-methyl-5-[3-(4-methylsulfinylphenyl)-1-benzofuran-5-yl]-1,3,4-oxadiazole
TCS 2002 (Compound 9b) is a highly selective, orally bioavailable and potent GSK-3β inhibitor with the IC50 of 35 nM
ChemicalCAS1005201-24-0MW338.38FormulaC18H14N2O3S
- CAS number
- 1005201-24-0
- Molecular weight
- 338.38
- Formula
- C18H14N2O3S
- Solubility
- <33·84mg/ml in DMSO; <8·46mg/ml in ethanol
- InChIKey
- RCKYSTKYIVULEK-UHFFFAOYSA-N
- Catalogue number
- GC11627
- Brand
- GLPBIO
Computed properties PubChem CID 24855958 · XLogP 3 · TPSA 88.3 Ų · H-bond donors 0
- XLogP
- 3
- TPSA
- 88.3 Ų
- H-bond donors
- 0
- H-bond acceptors
- 6
- Rotatable bonds
- 3
- Heavy atoms
- 24
SMILES CC1=NN=C(O1)C2=CC3=C(C=C2)OC=C3C4=CC=C(C=C4)S(=O)C
Computed descriptors from PubChem (CID 24855958), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il